Results 151 to 160 of about 7,193 (177)

Fabry disease: Lyso-Gb3 normalization as a reachable therapeutic goal

Molecular Genetics and Metabolism, 2023
Fernando J. Perretta, Juan M. Politei
openaire   +1 more source

Expanded analysis of Lyso-GB3 analogues and correlation with total Lyso-GB3 and Fabry status in 59 clinical patients

Molecular Genetics and Metabolism, 2018
Brian Netzel, Dimitar Gavrilov, Dietrich Matern, Devin Oglesbee, Kimiyo Raymond, Piero Rinaldo, Silvia Tortorelli, Matthew Schultz   +7 more
openaire   +1 more source

Plasma lyso-Gb3 as a diagnostic marker for Fabry disease

Molecular Genetics and Metabolism, 2018
Sarah Young, Haoyue Zhang, Jian Dai, Patricia McCaw, James Beasley, Denise Peterson, Ashlee Stiles, Marie McDonald, Dwight Koeberl, Deeksha Bali   +9 more
openaire   +1 more source

Effect of lyso-Gb3 on the intestinal microbiota may contribute to gastrointestinal symptoms in Fabry’s disease patients

2020
[Results]: Lyso-Gb3 significantly modified the growth of different bacterial groups of the human intestinal microbiota.
Aguilera-Correa, John-Jairo, Sánchez-Niño, María Dolores, Ortiz, Alberto, Sáez Martínez, Esteban F., Martínez-Cuesta, M. Carmen, Peláez, Carmen, Esteban, Jaime, Requena, Teresa   +7 more
openaire   +1 more source

Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

Genetics in Medicine, 2021
Atul Mehta, Christiane Auray-Blais, Raphael Schiffmann   +2 more
exaly  

Transcriptomics characterization of lyso-Gb3 impact on cultured wild-type human podocytes

Molecular Genetics and Metabolism, 2020
Maria Dolores Sanchez-Niño, Alberto Ortiz   +1 more
openaire   +1 more source

What about the excretion of lyso-Gb3 in Fabry adults compared to children?

Molecular Genetics and Metabolism, 2014
Christiane Auray-Blais, Catherine-Marie Blais, Michel Boutin, Pamela Lavoie   +3 more
openaire   +1 more source

8. How useful is urinary lyso-Gb3 as a biomarker for Fabry disease?

Molecular Genetics and Metabolism, 2010
Christiane Auray-Blais, René Gagnon, David G. Warnock, Sarah P. Young, David S. Millington, Joe T.R. Clarke   +5 more
openaire   +1 more source

A specific, sensitive, simplified and fast LC-MS/MS method for plasma Lyso-GB3 levels

2019
[No abstract available]
Canbay, E., Sezer, E., Ucar, S. Kalkan, Coker, M., Sozmen, E.   +4 more
openaire   +1 more source

Lyso-Gb3: A valid follow-up marker of treatment in male Fabry disease patients?

Molecular Genetics and Metabolism, 2020
Susanne Walls, Miia Rainto, Ilkka Kantola   +2 more
openaire   +1 more source